Esperion Therapeutics, Inc.: accounts_payable
| Value | {"amount": 24558000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2023-06-30) |
| Status | current |
| Entity | Esperion Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:06:45.971287+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a00e4a19-b24d-46da-aa7b-bcc3ff6a6f5c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-23-026358Retrieved: 2026-08-19T14:06:45.971287+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434868/accounts-payable/2023-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a00e4a19-b24d-46da-aa7b-bcc3ff6a6f5c
History
- no predecessors — first report